ProtoKinetix, Inc. (PKTX) Financial Statements (2025 and earlier)

Company Profile

Business Address 109 W. MAIN ST.
DALTON, OH 44618
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 20,40825,55057,568193,445377,349136,029
Cash and cash equivalent 20,40825,55057,568193,445377,349136,029
Prepaid expense1,0501,05025,9951,0501,0501,050
Total current assets:21,45826,60083,563194,495378,399137,079
Noncurrent Assets
Intangible assets, net (including goodwill)459,099436,270362,671274,686207,508187,771
Intangible assets, net (excluding goodwill)459,099436,270362,671274,686207,508187,771
Total noncurrent assets:459,099436,270362,671274,686207,508187,771
Other undisclosed assets      
TOTAL ASSETS:480,557462,870446,234469,181585,907324,850
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:44,69641,53093,26827,00025,52078,885
Accounts payable44,69641,53093,268   
Other undisclosed accounts payable and accrued liabilities    27,00025,52078,885
Other undisclosed current liabilities    (9,041)  
Total current liabilities:44,69641,53093,26817,95925,52078,885
Noncurrent Liabilities
Other undisclosed noncurrent liabilities    27,000  
Total noncurrent liabilities:    27,000  
Total liabilities:44,69641,53093,26844,95925,52078,885
Equity
Equity, attributable to parent435,861421,340352,966424,221560,387245,965
Common stock1,8501,7261,5911,5311,4721,389
Additional paid in capital48,297,96947,868,09345,892,54543,615,32336,107,05831,594,822
Accumulated deficit(47,863,958)(47,448,479)(45,541,170)(43,192,633)(35,548,143)(31,350,246)
Other undisclosed equity    1  
Total equity:435,861421,340352,966424,222560,387245,965
TOTAL LIABILITIES AND EQUITY:480,557462,870446,234469,181585,907324,850

Income Statement (P&L) (USD)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating expenses(415,479)(1,907,309)(2,329,310)(7,644,490)(4,197,897)(1,216,343)
Operating loss:(415,479)(1,907,309)(2,329,310)(7,644,490)(4,197,897)(1,216,343)
Interest and debt expense      (306)
Loss from continuing operations:(415,479)(1,907,309)(2,329,310)(7,644,490)(4,197,897)(1,216,649)
Loss before gain (loss) on sale of properties:(2,329,310)(7,644,490)(4,197,897)(1,216,649)
Net loss:(415,479)(1,907,309)(2,329,310)(7,644,490)(4,197,897)(1,216,649)
Other undisclosed net income attributable to parent      306
Net loss available to common stockholders, diluted:(415,479)(1,907,309)(2,329,310)(7,644,490)(4,197,897)(1,216,343)

Comprehensive Income (USD)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(415,479)(1,907,309)(2,329,310)(7,644,490)(4,197,897)(1,216,649)
Comprehensive loss, net of tax, attributable to parent:(415,479)(1,907,309)(2,329,310)(7,644,490)(4,197,897)(1,216,649)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: